Answers are grounded in this paper and cite their sources.
Assessment of immunophenotypic abnormalities of maturing/mature BM cells allows an efficient discrimination between MDS and both normal and reactive BM, once the number and degree of severity of the abnormalities detected are simultaneously scored. Interestingly, progressively higher IS were found among patients with MDS with adverse prognostic features and shorter overall survival.
No takes yet. Share an insight, caveat, or question.
Matarraz et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: